Cambridge University Autism expert Professor Simon Baron Cohen is already on record explaining why autism has an environmental and not solely genetic cause:-
The authors of a new paper just published in the journal Pediatrics are being reported as suggesting that autism and gastrointestinal disorders occur together solely as a result of an individual’s genetic make-up. However, this is contrary to the results and work of the lead author of the paper, Dr Pat Levitt of the University of Southern California.
A presentation of work by Dr. Levitt during the Autism and the Environment Workshop conducted by the US Institutes of Medicine in April 2007 is worthy of review. On page 31 of the report of those proceedings Dr. Levitt states that the variant of MET, SP1, associated with ASD, is affected in its expression by environmental toxins.
Dr Levitt has researched the relationship between MET genetic polymorphism and autism. The MET polymorphism occurs in almost 50% of the population. It is clear factors other than genetics play an important, even dominant, role in determining which children have GI problems that are associated with the MET polymorphism.
So, contrary to the news releases that the MET gene finding shows that the correlation between ASD and GI disease is purely genetic, the work on MET variants and autism shows just the opposite, that susceptibility factors such as the common variants of the MET gene, make individuals more susceptible to environmental toxins.
The new paper is Distinct Genetic Risk Based on Association of MET in Families With Co-occurring Autism and Gastrointestinal Conditions. Pediatrics, 10.1542/peds.2008-0819, Daniel B. Campbell, Timothy M. Buie, Harland Winter, Margaret Bauman, James S. Sutcliffe, James M. Perrin, Pat Levitt.
Eurekalert is a service provided free to journalists by the American Association for the Advancement of Science and has no independent external unbiased and objective control or scrutiny over the information published by the Eurekalert service to the media. Funders of AAAS and Eurekalert include GlaxoSmithKline, Merck & Co Inc, Johnson & Johnson Pharmaceutical Research and Development, Pfizer Inc and Roche Pharmaceuticals.
Dr. Pat Levitt is quoted in a 2006 press release from Vanderbilt University reporting the same research [emphasis added]:
In the current study, Levitt and colleagues analyzed the MET gene in more than 700 families who had at least one child with autism. They found that children with autism commonly had a specific change in the sequence of the promoter region of the gene, the part of the gene that regulates the amount of MET protein produced.”
‘This variant is in the part of the gene that controls how much of the gene gets expressed…kind of like ‘volume control’ on a stereo,’ Levitt says.
People with two copies of this variant were 2.27 times as likely to have autism as the general population. Individuals with only one copy were also at higher risk (1.67 times) than those without the variant.
“This is a relatively common variant, seen in about 47 percent of the population,” Levitt says. “So why doesn’t everybody have autism?”
That speaks to environmental and other genetic contributions, Levitt says.
“Genes create a vulnerability that then gets coupled with some environmental disturbance — but right now, we don’t have any idea what those factors might be.”
For a useful discussion of the topic, see the comments on this blog:-
Filed under: ADHD, Aspergers, autism, Barak Obama, Child Health Safety, Disease Statistics, Hannah Poling, John Poling, MMR, Obama, vaccination, vaccine, vaccine court, Vaccine Damage, Vaccines Tagged: | ADHD, Andrew Wakefield, Aspergers, autism, Barak Obama, Baron Cohen, CDC, David Kirby, fraud, genetic, genetics, Hannah Poling, immunisation, Jon Poling, Julie Gerberding, MMR, Obama, Professor Baron Cohen, Professor Simon Baron Cohen, research, research fraud, Simon Baron Cohen, vaccination, vaccine, vaccine adverse reaction, Vaccine Damage, vaccine risks, Vaccines, Wakefield